Return of secondary findings in genomic sequencing: Military implications

Genomic sequencing has become a widely used tool in clinical and research settings in both civilian and military healthcare systems.

• Publication year

  2018

• Venue

  Molecular Genetics & Genomic Medicine

• Publication date

  2018-11-10

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mgg3.483PMID 30415494PMCID 6393684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• KCNQ1 Gene

  2020cited by this paper
• Updated guide for the management of malignant hyperthermia

  2018cited by this paper
• Return of secondary findings in genomic sequencing: Military implications

  2018cited by this paper
• KCNQ1 Gene Variants in Large Asymptomatic Populations: Considerations for Genomic Screening of Military Cohorts.

  2017cited by this paper
• Malignant Hyperthermia Susceptibility and Fitness for Duty.

  2017cited by this paper
• Military genomics: a perspective on the successes and challenges of genomic medicine in the Armed Services

  2017cited by this paper
• Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

  2016cited by this paper
• Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study

  2016cited by this paper
• Genomic medicine in the military

  2016cited by this paper
• Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers.

  2016cited by this paper
• How Geisinger made the case for an institutional duty to return genomic results to biobank participants

  2016cited by this paper
• Identification of Medically Actionable Secondary Findings in the 1000 Genomes

  2015cited by this paper
• Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

  2015cited by this paper
• Improving awareness of nonanesthesia-related malignant hyperthermia presentations: a tale of two brothers.

  2014cited by this paper
• Presence of Two Different Genetic Traits in Malignant Hyperthermia Families: Implication for Genetic Analysis, Diagnosis, and Incidence of Malignant Hyperthermia Susceptibility

  2002cited by this paper

• Sharing Clinically Relevant Research Results with Active-Duty Special Operations Forces: Toward an Ethical Framework for Responsible Disclosure

  2026cites this paper
• Are genetic counselors prepared to counsel active‐duty service members? A survey of genetic counselors' self‐efficacy, counseling techniques, and knowledge of military policy

  2022cites this paper
• Navigating the ethical maze of genomics in Canada’s military

  2021cites this paper
• Genetic Counseling Considerations for Military Beneficiaries.

  2021cites this paper
• Airmen and Healthcare Providers’ attitudes toward the use of genomic sequencing in the US Air Force: Findings from the MilSeq Project

  2020cites this paper
• Ubuntu philosophy and the consensus regarding incidental findings in genomic research: a heuristic approach

  2020cites this paper
• Genetic testing strategies in the newborn

  2020cites this paper
• Educating military primary health-care providers in genomic medicine: lessons learned from the MilSeq Project

  2020cites this paper
• Educating military primary health-care providers in genomic medicine: lessons learned from the MilSeq Project

  2020cites this paper
• Patient‐centered care and genomic medicine: A qualitative provider study in the military health system

  2019cites this paper
• Return of secondary findings in genomic sequencing: Military implications

  2018cites this paper